Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-20

FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for Somavert (pegvisomant) from Pharmacia & Upjohn Company LLC to update/expand its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somavert (pegvisomant)

Snippet

SUPPL AP for SOMAVERT (PEGVISOMANT)